Cargando…
A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice
In the diseased and remodelled heart, increased activity and expression of Ca(2+/)calmodulin‐dependent protein kinase II (CaMKII), an excess of fibrosis, and a decreased electrical coupling and cellular excitability leads to disturbed calcium homeostasis and tissue integrity. This subsequently leads...
Autores principales: | Driessen, Helen E., Fontes, Magda S., van Stuijvenberg, Leonie, Brans, Maike A., Goumans, Marie‐Jose, Vos, Marc A., van Veen, Toon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412412/ https://www.ncbi.nlm.nih.gov/pubmed/32573944 http://dx.doi.org/10.1111/jcmm.15355 |
Ejemplares similares
-
Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015) -
Synaptic memory and CaMKII
por: Nicoll, Roger A., et al.
Publicado: (2023) -
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012) -
CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014) -
Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
por: Koyani, Chintan N., et al.
Publicado: (2018)